Those who applied for < ModaInnoChip(080420) > hit the upper limit in just 1 day! Achieved 32% profit!
Congratulations to everyone who applied for the free trial. ^^
※ For those who missed the “COVID-19 treatment,” don’t worry. We are going out strong once again.
※ Finally starting. ModaInnoChip(080420) follow-up stock hits the upper limit on Thursday. ※
The UK-based multinational subsidiary AstraZeneca has started Phase 3 clinical trials for the COVID-19 antibody treatment!!
According to Bloomberg and others, AstraZeneca stated, “In the coming weeks, two rounds of tests will begin on more than 6,000 people,” and “We plan to test an additional 4,000 adults for the antibody treatment.”!!
“I applied and bought small amounts every day for 3 days, and I was amazed that the upper limit profit came out every day. It’s really amazing how this is possible. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Really thankful again and again. Ah! I am actively recommending it to my acquaintances as well.”
(VIP office worker member Yoo Jin Lee, 41 years old)
Think of this as the last chance. If you miss this opportunity, you have to give up.
Exactly on “October 15” it will explode! Don’t miss it and regret it, buy at least 1 million KRW worth!
▶▶ Only 30 people will be given. “Thursday upper limit”! ▶ Receive now ◀
※ First-come, first-served 30 people closed! Both early and late rounds are over. The hero of the last injury time winning goal ※
[Today’s stocks of interest]
#KwangdongPharmaceutical #KoreaPharma #CTCBio #CMGPharmaceutical #KoreaUnionPharmaceutical
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
